Magenta Therapeutics, Inc. insider trading activity
Understanding Insider Activity at Magenta Therapeutics, Inc.
Welcome to our dedicated page for Magenta Therapeutics, Inc. (Nasdaq: DNTH) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Magenta Therapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Magenta Therapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for DNTH| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| DNTH | 8:00:40 PM, 10/3/2023 | Fairmount Funds Management LLC purchased 24670 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) for ~$336252 | Filing |
| DNTH | 9:09:20 PM, 9/28/2023 | Fairmount Funds Management LLC purchased 30000 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) for ~$394500 | Filing |
| DNTH | 8:15:07 PM, 9/25/2023 | Randhawa Simrat(Chief Medical Officer) purchased 4000 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) for ~$52800 | Filing |
| DNTH | 8:23:57 PM, 9/21/2023 | Fairmount Funds Management LLC purchased 30000 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) for ~$396000 | Filing |
| DNTH | 1:17:54 AM, 9/14/2023 | Fairmount Funds Management LLC purchased 24254 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) for ~$271678 | Filing |